These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34206297)

  • 1. Targeting Telomere Biology in Acute Lymphoblastic Leukemia.
    Karow A; Haubitz M; Oppliger Leibundgut E; Helsen I; Preising N; Steiner D; Dantonello TM; Ammann RA; Roessler J; Kartal-Kaess M; Röth A; Baerlocher GM
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
    Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
    Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
    Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
    Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
    Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
    Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
    Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
    Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
    Capraro V; Zane L; Poncet D; Perol D; Galia P; Preudhomme C; Bonnefoy-Berard N; Gilson E; Thomas X; El-Hamri M; Chelghoun Y; Michallet M; Wattel E; Mortreux F; Sibon D
    Exp Hematol; 2011 Feb; 39(2):195-202.e2. PubMed ID: 21056083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.
    Hu Y; Bobb D; Lu Y; He J; Dome JS
    Cancer Genet; 2014 Sep; 207(9):403-11. PubMed ID: 25441685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.
    da Mota THA; Camargo R; Biojone ER; Guimarães AFR; Pittella-Silva F; de Oliveira DM
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
    Wang Y; Fang M; Sun X; Sun J
    Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
    Barszczyk M; Buczkowicz P; Castelo-Branco P; Mack SC; Ramaswamy V; Mangerel J; Agnihotri S; Remke M; Golbourn B; Pajovic S; Elizabeth C; Yu M; Luu B; Morrison A; Adamski J; Nethery-Brokx K; Li XN; Van Meter T; Dirks PB; Rutka JT; Taylor MD; Tabori U; Hawkins C
    Acta Neuropathol; 2014 Dec; 128(6):863-77. PubMed ID: 25120190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.
    Marian CO; Cho SK; McEllin BM; Maher EA; Hatanpaa KJ; Madden CJ; Mickey BE; Wright WE; Shay JW; Bachoo RM
    Clin Cancer Res; 2010 Jan; 16(1):154-63. PubMed ID: 20048334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
    Vasko T; Kaifie A; Stope MB; Kraus T; Ziegler P
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.
    Chan D; Martin-Ruiz C; Saretzki G; Neely D; Qiu W; Kunadian V
    PLoS One; 2020; 15(1):e0227616. PubMed ID: 31923255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Initial Telomere Length, Initial Telomerase Activity, Age, and Replicative Capacity of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs: What Is a Predictor of Replicative Potential?
    Lee JS; Jeong SW; Cho SW; Juhn JP; Kim KW
    PLoS One; 2015; 10(12):e0144177. PubMed ID: 26633809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
    Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
    Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
    Wu KD; Orme LM; Shaughnessy J; Jacobson J; Barlogie B; Moore MA
    Blood; 2003 Jun; 101(12):4982-9. PubMed ID: 12609839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
    Chiappori AA; Kolevska T; Spigel DR; Hager S; Rarick M; Gadgeel S; Blais N; Von Pawel J; Hart L; Reck M; Bassett E; Burington B; Schiller JH
    Ann Oncol; 2015 Feb; 26(2):354-62. PubMed ID: 25467017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.